Arzerra
29/10/2009
FDA Approves Ofatumumab (Arzerra) for Patients With CLL Refractory to Fludarabine and Alemtuzumab
ACTEMRA (Tocilizumab) approved in Switzerland for use in Rheumatoid Arthritis
18/12/2008
RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid ArthritisFirst-in-class therapy represents a novel approach to treat patients with moderate to severe rheumatoid arthritis.
Cladribine injectable Lipomed available by Unipharma
05/12/2008
LITAK® is approved for recurrent or refractory follicular and diffuse non-Hodgkin's lymphoma, recurrent or refractory chronic lymphocytic leukemia and recurrent or refractory lymphoplasmacytic lymphoma (Waldenström's macroglobulinemia) in Switzerland (country of origin) since 2000.
Activé le système de consultation en ligne Unipharma
17/11/2008
Il a été activé système de consultation en ligne des médicaments qui Unipharma offre sur le marché. Vous pouvez demander l'activation d'un compte d'accès.
Acquisition de Pharmion par Celgene
17/11/2008
Unipharma a été confirmé en tant que distributeur exclusif pour l'Italie et de Vidaza thalidomide Pharmion.
Bayer’s Novel Anticoagulant Xarelto® now also Approved in the EU
02/11/2008
Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care
Adresses
DIVISION IMPORT EXPORT
Tel. +41 (0)91 985 62 11Fax. +41 (0)91 985 62 22
Clients: sales@unipharma.ch
Fournisseurs: purchase@unipharma.ch
SIEGE
Unipharma SA Via Pian ScairoloCH - 6917 Barbengo, Lugano
Tel. +41 (0)91 985 62 11
Fax. +41 (0)91 985 62 22
General: unipharma@unipharma.ch